Evidence map›Paper›PMID 42125027›Full record

ArticleEuropean heart journal open2026

Population-level cardiovascular risk prediction models including biochemical predictors in 800 000 individuals.

Bruno Batinica, Suneela Mehta, Jingyuan Liang, Rod Jackson, Katrina Poppe

Abstract read
In one paragraph

Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruno BatinicaSection of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, 22-30 Park Ave, Grafton, 1023, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-5525-9007
Suneela MehtaSection of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, 22-30 Park Ave, Grafton, 1023, Auckland, New Zealand.
Jingyuan LiangSection of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, 22-30 Park Ave, Grafton, 1023, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-3489-5776
Rod JacksonSection of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, 22-30 Park Ave, Grafton, 1023, Auckland, New Zealand.ORCID https://orcid.org/0000-0001-5914-6934
Katrina PoppeDepartment of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22-30 Park Ave, Grafton, 1023, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-4418-4476

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Most countries lack the clinical cohort data required to create cardiovascular disease (CVD) risk prediction models and rely on models developed elsewhere. However, individual-person linkage of health administrative databases enables the creation of local models. Objectives: This study aimed to explore whether the addition of routine biochemical tests could improve the performance of 'administrative data-based' models. Methods and results: Estimated glomerular filtration rate, haemoglobin A1c, total cholesterol/high-density lipoprotein cholesterol ratio, and triglyceride tests performed on one-third of New Zealand adults were identified and linked to national administrative health datasets (11 564 665 tests). Sex-specific Cox models estimating 5-year CVD in people aged 30-74 without prior CVD were developed, internally and temporally validated, and compared, including and excluding the four biochemical predictors. 805 817 individuals were included, of whom 64% had all four examined test results available. 1.8% of women and 3.4% of men experienced a CVD event during 4.7 years mean follow-up. All biochemical predictors except triglyceride level in men were statistically significant independent predictors of CVD risk. The addition of these predictors improved global model performance metrics over models without biochemical predictors and identified 34% of men and 28% of women in the cohort who accounted for 75% of all CVD events, respectively. Conclusion: Biochemical predictors improved the performance of administrative data-based CVD risk prediction models, illustrating the untapped potential of widely available databases. Similar models could be developed in many countries and healthcare organizations if health administrative databases were linked. These models could be remotely applied across populations to inform CVD prevention policy and practices. Condensed abstract: Novel CVD risk prediction models have recently been developed in New Zealand and Denmark from predictors available in health administrative data, but their performance is limited by their parsimony. Biochemical predictors are now linkable to New Zealand administrative datasets and we show that they improve the predictive ability of previous 'administrative data-based' models. These new models were remotely deployed across a large New Zealand region, identifying 27% of individuals who accounted for 74% of subsequent CVD events. Similar models could be created in many countries and healthcare organizations to aid population health planning efforts, investigate equity gaps, and pre-screen populations who experience difficulties accessing traditional health services.

Indexed as

Biochemical markersCardiovascular diseaseHealth administrative dataRisk prediction

Identifiers

PMID42125027
PMCPMC13160000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.